24-05-2012

France Biotech in partnership with Ernst & Young, published for the 10th year running the 'Life Science Panorama', describing the industry's main trends for 2010/2011 in France and worldwide. This time, almost 200 French companies took part in the survey. The panorama highlights the maturity ...

more

01-04-2011

France Biotech presented the results of its "Life Science Panorama 2010" survey at BioVision in Lyons. The survey describes the main trends for 2009/2010 in the life science industry in France and internationally. Over 263 companies responded to the survey this year and 211 were included in ...

more

Six new members join the Administrative Council

02-07-2009

At the Annual General Meeting, the members of France Biotech voted to elect their governing bodies, in accordance with the organization's statutes. The newly elected Administrative Council then appointed André Choulika as Chairman. He succeeds the outgoing Chairman Philippe Pouletty MD, who ...

more

In 2008, the number of drugs and medical devices in late-stage development rose markedly, thanks to significant levels of investment over the period 2005-2007

04-03-2009

France Biotech has published the 3rd edition of its annual Drug Pipeline Review. The survey was part-funded by the French Ministry of the Economy, Industry & Finance. The study summarizes and analyses data collected in 2008 on 227 healthcare products under development, including 158 drugs ...

more

Asking the government to implement a stimulus plan for young, innovative companies

10-02-2009

France Biotech has reported a major drop in equity investments in French biotech companies: funding fell by 79% in 2008, relative to 2007 (€143 million in 2008 versus €694 million in 2007). Investment in listed companies collapsed (only €12 million in 2008 - a fall of 98%). Venture capital ...

more

09-10-2008

While the French biotechnology industry has been hit by the temerity of stock market investors, the launch of Euronext’s Next Biotech Index provides greater visibility for the sector, thereby rendering it more attractive. Growth and innovation are both evident in the product and service ...

more

27-11-2006

The European Commission has just published new state aid rules - backed by a communication on tax incentives to stimulate R&D. The new rules recognize EuropaBio's Young Innovative Companies (YIC) status as an eligibility criterion for state aid. This will enable Member States - who so wish - ...

more

25-10-2006

As the candidates in France's 2007 presidential elections continue to prepare their campaign platforms, France Biotech, the French biotechnology industry association, presents three key proposals for promoting the maturation of biotechnology SMEs at the various stages of their development ...

more

21-11-2005

Five national biotech associations representing the Swedish, Finnish, Norwegian and Estonian biotech industries announced that they have started a joint-project aimed at the evaluation of a national implementation of the Young Innovative Company (YIC) status to support the creation ...

more

France Biotech unveils « 2004 French Biotechnology Industry Report » on December 15th in Paris

20-12-2004

France Biotech, the French biotechnology industry association, presented the « 2004 French Biotechnology Industry Report » results. This third edition of 2004 describes the main developments in the biotechnology sector in 2003, as well as the trends, and the 2004 financing activities. In ...

more